Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 3,892 | 11,240 | 6,362 |
| Cost of Goods | N/A | N/A | 2,560 | 4,097 | 3,173 |
| Gross Profit | N/A | N/A | 1,332 | 7,143 | 3,189 |
| Operating Expenses | 40,983 | 39,663 | 83,598 | 137,485 | 99,593 |
| Operating Income | -40,983 | -39,663 | -81,706 | -130,245 | -96,231 |
| Interest Expense | 5,783 | 5,814 | 7,266 | 8,380 | 8,589 |
| Other Income | 8,255 | 3,278 | 44,150 | -3,980 | 493 |
| Pre-tax Income | -38,511 | -42,199 | -44,822 | -142,605 | -104,327 |
| Net Income Continuous | -38,511 | -42,199 | -44,822 | -142,605 | -104,327 |
| Net Income | $-38,511 | $-42,199 | $-44,822 | $-142,605 | $-104,327 |
| EPS Basic Total Ops | -10.15 | -17.35 | -29.48 | -108.32 | -99.50 |
| EPS Basic Continuous Ops | -10.15 | -17.35 | -29.47 | -108.36 | -99.59 |
| EPS Diluted Total Ops | -10.15 | -17.35 | -29.48 | -108.32 | -99.50 |
| EPS Diluted Continuous Ops | -10.15 | -17.35 | -29.47 | -108.36 | -99.59 |
| EPS Diluted Before Non-Recurring Items | -10.15 | -17.35 | -29.48 | -109.50 | -99.50 |
| EBITDA(a) | $-39,476 | $-38,107 | $-79,744 | $-127,751 | $-94,265 |